Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Interesting perspective

<< Previous

Bullboard Posts

Next >>

Comment by fredgoodwinsonon Dec 14, 2021 1:34pm

645 Views

Post# 34229707

RE:RE:Interesting perspective

Here primarily for what x-ray activated Rutherrin may do against deep cancers but in addition to NMIBC there are many superficial cancers with less than satisfactory outcomes for which TLD-1433 may prove suitable.

Difficult to reconcile the thin-ness of the buy side at these modest levels with the Clinical data from the last Newsletter but continue to add.

<< Previous

Bullboard Posts

Next >>

Canopy Growth nears adjusted EBITDA profitability in Q2 2025